In February 2011, Monsanto Company acquired Divergence Inc for an undisclosed amount. Now operating as a subdiuary of Monsanto, Divergence is organized around the discovery and development of genes and molecules for the control of nematodes or roundworms that cause disease in humans, other animals, and plants. The firmsâ products include nematicides, nematode resistant crops, anti-parasitic drugs, fungicides, insecticides, herbicides, and nematode resistant crops; and products developed by the firm are used for applications such as crop protection, veterinary medicine, and human health. Divergence has focused its work on parasitic nematodes, including the development of biotechnology traits for nematode control and nematicides with novel modes of action and superior safety profiles. Nematodes cost farmers millions in damages annually to crops like corn, soy, cotton and vegetables. Divergenceâs pipeline includes a nematicide that could be used as a valuable seed treatment formulation to maximize the performance potential of the seeds and traits farmers pla